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Macroscopic hydrogels are commonly used as injectable scaffolds or fillers, however they 
may easily obstruct blood vessels, which poses risks and limits their clinical use. In the 
present study, three types of hyaluronic acid (HA)-based hydrogel micro-particles with non-
covalent, covalent semi-interpenetrating and conventional 3D molecular networks 
respectively, have been designed, fabricated and characterized. The micro-particles are 
spherical, biconcave or irregular in shape and their diameter ranged between 2.5 and 3.5 µm; 
their suspensions exhibit a tuneable viscosity, shear-thinning behaviour, dynamic stability and 
dispersity in microfluidic flow as a result of their specific particulate nature, providing thus a 






enhanced safety profile, in terms of the dispersity, cell safety, and hemocompatibility. In 
addition, Rhodamine 6G has successfully been loaded and released from the particles as a 
model for drug delivery. Functionalisation of hydrogel microparticles using synthetic 
polymers has been proven to be a cost-effective way to achieve desirable rheological 
properties and flow dynamic stability with improved physicochemical properties and 
biocompatibility in vitro, showing promise as a multifunctional biomedical material for 




Macroscopic hydrogels are commonly used in the biomedical field, including scaffolds in 
tissue engineering,[1] vehicles for drugs or biomolecules,[2] and surgical materials.[3, 4] A 
common and attractive property of hydrogels lies in its injectability, which enables minimally 
invasive delivery. However, there is concern that hydrogels may block blood vessels, should 
the needle accidentally hit a vessel, as seen in soft tissue fillers or drug delivery systems. In 
some instances, such a blockage may result in serious complications, including massive tissue 
necrosis and blindness.[5] To make matters worse, there is no effective cure for such 
complications. Thus, much attention has been drawn to preventive measures, including 
anatomical education and introduction of blunt-tip cannulae.[6, 7] Unfortunately, these 
measures are not sufficient to eliminate such complications. Also, they are not suitable for 
every clinical situation.[8] Considering the high vascular density in certain tissue areas and 
the anatomical varieties, it is difficult to avoid at least some level of blood vessel damage 
during actual procedures. 
One of the most important shortcomings many hydrogels share is their complex rheological 
behaviour, which varies as a function of the specific composition and the structure of the 






polymeric hydrogels may ‘thin’ quickly, i.e. may flow easier due to a decrease in viscosity 
with an increase of the pressure applied, compromising the controllability of delivery. If this 
happens in a blood vessel, a gel embolus may form immediately. Such emboli would not 
respond to thrombolytics. Furthermore, in the case of polymers with high molecular weights, 
a high viscosity can be reached at a low concentration and/or crosslinking degree. Thus, when 
the hydrogels are used as drug delivery systems, there is a trade-off between the injectability 
and the releasing kinetics, resulting in a compromised tunability.  
As an important glycosaminoglycan existing in most of tissues of the human body, hyaluronic 
acid (HA) is widely used for tissue reconstruction and drug delivery due to its good 
biocompatibility and tuneable degradability. Meanwhile, synthetic polymers such as 
polyethylene glycol (PEG) and polyvinylpyrrolidone (PVP) are well known for their good 
hemocompatibility, molecular control and large-scale production. By combining the 
characteristics of natural and synthetic polymers, novel hybrid hydrogels can be developed, 
with improved physical/mechanical properties and biofunctions for various applications.[9-12] 
Since modification with hydrophilic molecules is a common method to further improve the 
hemocompatibility of biomaterials,[13] HA microgels functionalized with PEG or PVP, as a 
representative model of functionalized microgel system, may demonstrate both synergistic 
biocompatibility and hemocompatibility.[14] In comparison with the macroscopic and 
nanoscale counterparts, such a degradable microgel system is envisaged to improve 
cytological safety[15] and to cause less extensive ischemic damage with intravascular 
injection.[16] Meanwhile, it is expected to have good injectability and tunability, while 
maintaining good biocompatibility. 
In the present study, physically and chemically modified HA microgels were designed, 
manufactured and characterized, with formation of PVP-HA and PEG-HA hybrid network, 






commercial HA dermal fillers are typical representatives of macroscopic HA-based hydrogels, 
a commercial HA filler sample was also used as an important reference in the rheological and 
swelling tests. 
2. Material and methods 
2.1 Materials 
HA (average mw 500 kDa) was purchased from Bloomage Freda Biopharm Co., Ltd. PEG 
methyl ether (PEGME, mw 5 kDa), PVP (mw 10 kDa), Sorbitan monooleate (Span® 80), 
Rhodamine 6G, Hoechst 33258, 2-isopropanol, acetone, penicillin-streptomycin and light 
mineral oil were purchased from Sigma-Aldrich. Divinyl sulfone (DVS) was purchased from 
VWR. The Dulbecco's Modified Eagle Medium (high glucose, L-Glut, phenol red) and the 
foetal bovine serum were purchased from Life Technologies. The AlamarBlue reagent was 
purchased from invitrogen
TM
. Two millilitres of commercialized HA-based soft tissue fillers 
(BioHyalu, Freda Biopharm) was kindly provided by the Plastic Surgery Department, 
Nanfang Hospital, Guangzhou, China. 
2.2 Preparation of mHA, mHA/PEG, and mHA/PVP 
Hyaluronic acid was dissolved in deionised water to make the 10 mg/ml HA solution. 
PEGME and PVP were dissolved in deionised water to make 150 mg/ml solutions. DVS was 
dissolved in deionised water to make the 50 mg/ml solution.  
Several drops of 2M NaOH were added to 3 ml of the 10 mg/ml HA solution to adjust the pH 
value in the range of 11 to 12. 100 µl of 150 mg/ml PEGME solution (PVP solution for 
mHA/PVP, deionized water for mHA, respectively) were added to the HA solution. Span® 80 
was dissolved into mineral oil, with the volume ratio of 1 to 80. 12 ml of the resulting mineral 






An ultrasonic processor (Model CP-750, Cole Parmer, USA) with a converter (Model CV-33) 
was used to prepare the w/o emulsion. During the ultrasonication, an amplification of 30% 
was selected, and the ultrasonication was run for three minutes. During the process, 0.6 ml of 
50mg/ml DVS solution was added. The reaction was allowed to proceed for one hour at room 
temperature without intervention. 
Next, the oil phase was washed away with 16 ml isopropanol for mHA/PEG and mHA, and 
16 ml acetone for mHA/PVP. Following agitation, the mixtures were centrifuged at 3000 rpm 
for 15 minutes. The precipitate was collected and washed several more times. The precipitate 
was dried under a negative pressure and re-suspended in deionised water.  
2.3 Characterization 
2.3.1 Fourier transform infrared spectroscopy 
All FTIR measurements were carried out with Jasco FT/IR-4200 (Jasco Co. Ltd., Japan). 
Absorbance spectra were recorded for uncrosslinked HA, mHA/PVP, mHA/PEG, and mHA. 
In order to fit the baseline and to minimise the effects of the slopes on absorbance peaks, 
Essential FTIR
TM
 v.3.50 was used to analyse the raw data and generate second derivative 
spectra, with the Savitsky-Golay algorithm as the smoothing method. The derivative spectra 
were further manipulated with vector normalization to correct the scattering effect and to 
normalize the baseline. The intensity of N-H bending peak was measured. The N-H bending 
intensities in mHA/PVP, mHA/PEG and mHA were compared to that of uncrosslinked HA, to 







2.3.2 Dynamic light scattering assay 
In order to determine the average size of the particle units, including individual hydrogel 
particles and particle clumps in the suspension, dynamic light scattering (DLS) measurements 
and analysis were performed with a DelsaMax Pro analyser (Beckman Coulter, Inc, USA). 
For each suspension, a concentration of 2 mg/ml (0.2 wt %) was used to run the assay. The 
measurements were carried out at 25 °C. The average sizes, and size distribution (the PDI) of 
the peaks were recorded. 
2.3.3 Particle morphology 
The particle sizes were confirmed with a scanning electronic microscope (SEM, LEO 
1540XB, Zeiss, Germany). To prepare the SEM samples, diluted suspensions were dropped 
on adhesive carbon tabs, placed on SEM stubs, and lyophilized overnight. After the freeze-dry 
procedure, the samples were coated with gold and stored in a vacuum desiccator prior to the 
analysis.  
2.3.4 Rheological characterisation 
A rheometer (Malvern) was employed to assess the rheological behaviour of suspensions of 
mHA/PVP, mHA/PEG, mHA, as well as the commercial filler. The concentration of the 
commercial filler sample was measured to be 50 mg/ml (i.e. 4.8 wt% or 2.8 vol%, HA 
density= 1.8 g/cm
3
).by weight measurement after freeze-drying. Samples used in rheological 
assessment shared the same concentration as the commercial filler.  
A steady shear test was performed and flow curves of shear stress and effective viscosity 
versus shear rate respectively were generated for each sample.  A frequency sweep was also 
applied to every sample, in order to characterise the dynamic viscoelasticity of the three 
suspensions at a low strain amplitude (0.5%). The stress-strain relationship of all three 








where τy is the yield stress, K the consistency and n the flow index. The parameters of the 
model fitted to the acquired data were calculated and listed in Table 1. 
2.3.5 Microfluidic experiments with hydrogel particle suspension flows 
In order to understand the behaviour of the particles in the blood stream, microfluidic 
experiments were conducted to preliminarily study the flow field of the suspensions upon 
entering a continuous flow stream. 
Microfluidic system set up 
A pressure controlled perfusion system described elsewhere[18] was used to deliver the 
suspension flows through the side branch of a rectangular T-junction microfluidic device 
comprising a 500µm wide microchannel with a 100 µm wide branch. The height of the 
channels was 100 µm resulting in an aspect ratio of 5:1 in the main channels and 1:1 in the 
side branch. The microchannel was made of polydimethylsiloxane (PDMS) and fabricated 
using standard soft lithography techniques. [19] 
The microfluidic channel was placed on an inverted microscope (DMILM: Leica, Germany) 
with a 10x objective.  The flow was illuminated by a green LED microstrobe and a 
Hamamatsu C8484-05C CCD camera (Hamamatsu, Japan) was used for imaging. A 35 vol% 
glycerol in aqueous solution was perfused into the 500 µm main channel, with a flow rate of 
100 µL/min, using a syringe pump. Particle suspensions (20 mg/ml) were injected through the 
100 µm branch in a continuous manner, using the  pressure control system [18]. An external 
injection pressure of 28kPa was applied to the syringe to simulate the injection process and to 






Characterisation of Hydrogel Particle Micro-Flow Dynamics 
 60 successive image pairs of the microgel flows were acquired at a time interval of 0.5 ms 
upon entering the microfluidic T-junction and 1 cm (20 channel widths) further downstream 
in order to compare the ensuing flow patterns for the different samples and to observe any 
potential particle aggregation. Using the hydrogel particles as tracers, multipass cross-
correlation, micro-particle image velocimetry (µPIV) algorithms were implemented in JPIV 
v13.08 (www.jpiv.vennemann-online.de) in order to determine the velocity field. The inlet 
flow velocities of the microgel suspensions were estimated from the PIV data. These were: 60 
mm/s for mHA/PVP, 19 mm/s for mHA/PEG and 52 mm/s for the mHA. The continuous 
phase flow velocity was kept constant at 33.3 mm/s and the corresponding dispersed to 
continuous phase velocity ratios (ud/uc) were 1.8, 0.6 and 1.6 respectively. The viscosity ratios 
(d/c) were 0.17, 0.6 and 0.4 for the mHA/PVP, mHA/PEG and mHA respectively.  
2.3.6 Swelling ability 
The dried precipitate was dipped into deionized water for one hour. The supernatant was 
removed, and the surface of the precipitate was dried by a piece of absorbable tissue. The wet 
precipitate was weighed. The wet precipitate was then dried again and weighed. 
The mass swelling ratio (MSR) was calculated as follows: 
 
2.3.7 In vitro enzymatic degradation assessment 
Excessive particle aggregations were added into 2 ml of hyaluronidase solution (0.5 mg/ml). 
The mixture was placed in a centrifuge tube, and was incubated at 37 °C for 1.5 hours and 3 
hours, respectively. Then, the supernatant was collected. In order to ensure complete 






colorimetry was carried out with Ehrlich’s reaction. The absorbance at 562 nm was measured 
with a plate reader (BioTek Instruments, USA), and the molar concentration of N-acetyl-D-
glucosamine was calculated with a standard curve. Three batches of samples were measured. 
2.3.8 Effects on thrombosis 
Thromboelastography (TEG 5000, Thrombelastograph® Analyzer, Haemoscope, USA) was 
employed to assess the effect of hydrogel particles on thrombosis. Citrated whole blood was 
tested (HTA Licence: 11016; project code: NC2016.006). A total volume of 360 µl was used 
in the test. Twenty microliters of calcium chloride (CaCl2) were added with 36 µl suspension 
(25 mg/ml) into 304 µl fresh citrated whole blood. To mimic the diluting effect of adding 
suspensions, a PBS control was used to dilute blood to the same extent. The test was run as 
long as stable values were obtained. The values of angle α and maximum amplitude (MA) 
were selected to compare the effect of suspensions on thrombosis.  
2.3.9 Effects on cell metabolism and viability 
Human dermal fibroblasts (HDFs, passage 15) were used to test the subacute toxic effects of 
hydrogel particles. The test included two different final concentrations of each suspension, i.e. 
1 mg/ml and 2 mg/ml. PBS control groups were used. HDFs were cultured in 48-well plates, 
6200 cells each well, with 500 µl culture medium each well, and incubated at 37°C. Single 
doses were given to all the cell cultures. The dosages were delivered 24 hours after seeding 
the cells, when anchorage was confirmed with an optical microscope. The alamarBlue assay 
was used to evaluate the effect on metabolism, and the total DNA quantification was used to 
assess the effect on viability. After receiving single doses, the cells were tested on day 6.  
In the alamarBlue test, a positive control was prepared by autoclaving the reagent-media 
mixture for one cycle. A no-cell control was prepared by incubating the mixture at 37℃. A 






reduction rate of the dye, with a pair of filters for excitation 570 nm and emission 620 nm. 
The reduction rate was calculated as follows: 
 
A commercial quantification kit was used for total DNA quantification. The same 
fluorescence plate reader was used, with a pair of filters for excitation at 355 nm and emission 
at 460 nm. 
2.3.10 Preliminary loading and release test 
In order to incorporate Rhodamine 6G into the hydrogel particles, a 20 µl 5mg/ml Rhodamine 
6G solution was added into the water phase before ultrasonication. The hydrogel particles 
were manufactured following the process described previously. 
The in vitro releasing test was carried out with washed precipitate loaded with Rhodamine 6G, 
under the enzymatic catalysis with bovine hyaluronidase. A fluorescence microscope (Nikon 
ECLIPSE Ni) was employed to assess the loading status of Rhodamine 6G, using excitation at 
532 nm. A UV-VIS spectrometer was used to measure the absorbance at 539 nm. The dried 
precipitate was cut to fit the bottom of 1.5 ml UV cuvettes and placed in such a way that the 
light pathway remained unobstructed. 1ml of deionised water and 0.5ml 1mg/ml 
hyaluronidase was added into the cuvettes, immediately followed by the measurement of time 
point 0. The measurement was carried out every 20 minutes, for 3 hours.  
2.3.11 Statistical analysis 
The IBM SPSS v23.0 software package was used to carry out the statistical analysis in the 
present study. The average values were compared with One-way ANOVA when homogeneity 







3. Results and discussion 
3.1 Synthesis of hydrogel micro-particles 
In the present study, an ultrasonic invert emulsion was used to manufacture the hydrogel 
particles. Compared to the invert emulsions generated by vigorous stirring,[20] 
ultrasonication improved the efficiency of particle production, reduction and uniformity of 
particle size resulting in more stable emulsions.[21] This is especially important for HA 










Figure 1. (a)-(c) Schematic showing semi-interpenetrating network of HA/PVP (a). 
interpenetrating network of HA/PEG (b) and network of HA(c). (d) FTIR spectra of the three 
hydrogel microparticles. (e) Vector normalized second order derivative FTIR spectra between 
1575 and 1595 cm
-1
, generated with the Savitsky-Golay algorithm, which narrowed the 
bandwidths and increased the resolution of differential spectra. In uncrosslinked hyaluronic 
acid, the peak around 1585 cm-1 represented N-H bending, which was used as a marker of 






As one of the most commonly used crosslinkers in the industry of HA-based fillers,[23] 
divinyl sulfone (DVS) was selected. The crosslinking reaction could take place at room 
temperature.[24] The reaction rate was high with most crosslinking completed within the first 
30 minutes,[25] which  is also important in terms of manufacturing efficiency. As for the final 
products, different crosslinking degrees can be achieved by altering the ratio of HA and 
DVS.[26] A mass ratio of 1:1 was used in the present study. This mass ratio was shown to 
result in a crosslinking degree as high as 90%.[26] Three types of hydrogel micro-particles 
with different polymeric networks were produced: non-covalent semi-interpenetrating 
mHA/PVP network, covalently bonded semi-penetrating mHA/PEG network and 
conventional mHA network, as illustrated in Fig. 1a-c.  
3.2 Size and morphology of hydrogel microparticles 
The average size of the fabricated hydrogel particle units was measured by dynamic light 
scattering. A dilute suspension of particles, 2 mg/mL (0.2 wt %) was employed in the DLS 
tests in order to minimise the potential aggregation and ensure that the particles were well 
dispersed. The results are summarized in Table 1. The average diameter of the polymer 
modified particles recorded from three repeated measurements was approximately 3.4 µm, 
with the smaller size of mHA, around 2.5 µm. Being smaller than red blood cells (about 8 
µm),[27] the hydrogel particles should  be able to flow through the capillary network without 
causing significant occlusion. Kruskal-Wallis analysis showed that the mean diameter of the 
particle units in mHA/PVP (3.39 ± 0.65 µm, mean rank = 9.4) was similar to that of 
mHA/PEG (3.44 ± 0.09 µm, mean rank = 11) (p > 0.99), while that of mHA (2.59 ± 0.42 µm, 
mean rank = 3.6) was significantly smaller (p < 0.04). The particles exhibited a low 
polydispersity index (PDI) in all suspensions characterised, and hence the particle size 
distributions can be considered near monodisperse (Table 1). However it should be noted that 






for all three particles based on an ideal sphere model.  The effects of the unknown refractive 
index of the hydrogels and non-spherical geometries of the particles (Fig. 2) on the 
measurements of the particles size and PDI require further investigation.   
Table 1. Summary of structure and properties of the peaks detected in hydrogel particle suspensions 
 mHA/PVP mHA/PEG            mHA 
DLS No. of peak 1 1 1 
Mean particle 
diameter,(µm) 
3.39 ± 0.65  3.44 ± 0.09  2.59 ± 0.42  
Polydispersity index, PDI 0.07 ± 0.03 0.08 ± 0.03 0.15± 0.02 
Relative HA content% 56.9 ± 8.01 80.1 ± 2.04 84.5 ± 6.60 
Mass swelling ratio, MSR 7.01 ± 3.95 7.93 ± 3.39 10.40 ± 5.68 
 
The relative content of HA in the three particle types was quantified by FTIR (Fig 1d). 
Because the N-H bond is only present in HA and it remained unreacted throughout the 
manipulation, the relative intensity ratio of the N-H bending peaks was used to determine the 
relative content of HA in the three samples. The FTIR spectra were transformed to second 
derivative spectra, as shown in enlarged spectra between 1500 and 1600 cm
-1
, i.e. the amide II 
region, before vector normalization was applied to minimise the effects of scattering (Fig. 1e). 
A slight red shift was observed after the crosslinking, indicating that the reduction of the 
number of hydroxyl groups had an effect on hydrogen bonding. Despite of the red shift, all 
the corresponding peaks for the three particles were located between 1500 and 1600 cm
-1
.[28] 
The intensity of the peak is proportional to the molar content of the repeating units of HA 
molecules.  The intensity of the peaks was 0.055, 0.046, 0.044 and 0.031, in uncrosslinked 
hyaluronic acid, mHA, mHA/PEG, and mHA/PVP, respectively. Based on these results, the 






80.1%, and 56.9%, respectively. One-way ANOVA showed that the ratio was significantly 
lower in mHA/PVP, compared to that of mHA/PEG (p = 0.004) and mHA (p = 0.01).  
The HA content measured in the hydrogel particles may reflect different hydrogen bonding 
interactions between polymer molecules. Compared to the oxygen in the ether bond (-O-) of 
PEGME backbone, the oxygen on carbonyl double bond (>C=O) in cyclic amide side group 
of PVP is more electronegative[29, 30] and attractive to hydrogens bearing a partial positive 
charge. Therefore, a stronger hydrogen bonding network may form between PVP and HA 
chains, resulting in an increased amount of PVP incorporated. On the other hand, although 
PEGME may form covalent connections with HA, only one hydroxyl end group exists per 
molecule. Apparently, this was not sufficient to offset the effect of hydrogen bonds.  Previous 
studies also showed that PVP can form a more stable network compared to PEG; as a result, 
the interaction energies and the electron density may be affected.[31] Both carbonyl bond 
(>C=O) and cyclic amide (>N-) of PVP side groups can contribute to the hydrogen bond with 







Figure 2. SEM images showing the morphology of microparticles made from mHA/PVP (a) 







The particle morphology was assessed with SEM (Fig. 2). Most imaged particles exhibited a 
diameter between 1.5 and 3 µm, slightly smaller and less uniform than the DLS measurement 
results indicated in Table 1. Discrepancy of the particle measurements by different 
characterisation equipment is an existing issue due to the different principles and assumptions 
on which each technique is based. In the case of the SEM measurement, a small shrinkage of 
the hydrogel particles, caused by a freeze-dry process in the sample preparation, may be 
argued to be one of reasons that smaller particles were seen. Nevertheless, the morphology of 
the freeze-dried hydrogel particles provide more information about the shape and surface 
structure of the networks. In mHA/PVP (Fig. 2a) and mHA/PEG (Fig. 2b), spherical and oval 
particles with smooth surfaces were observed. Some of the mHA/PVP particles have a hollow 
core, like pitted olives (Fig. 2d), while most mHA/PEG particles show more dumbbell-like 
shape, reminiscent of biconcave red blood cells (Fig. 2e).  However, mHA particles exhibited 
a porous surface with an increased irregularity, both in shape and size (Fig. 2c and 2f). The 
different morphologies may be attributed to different 3D network structures in each particle as 
illustrated in Fig. 1a-1c. The smooth and condensed hydrogel particles indicate that a uniform 
3D network formed because of either non-covalent or covalent semi-interpenetration of PVP 
and PEG chains throughout the HA network. In the case of HA hydrogel alone, the porous 
morphology of mHA particles may indicate that a non-uniform local crosslinking reaction 
occurred with DVS resulting in a phase separation within the 3D network between densely 
crosslinked HA rich domains and water rich domains. This may be attributed to the non-
uniform distribution of DVS among the HA network with highly entangled molecular chains 
owning to the high molecular weight. 
In principle, the synthesised particles should be able to circulate through most of the capillary 
network of the human body in terms of their size (mean diameter 3 to 4 µm).[32] The 






number of local infarctions caused by larger particle aggregates/clumps are still possible. This 
indicates that the clinical safety profile of the synthesised particles is remarkably improved 
compared to macroscopic hydrogels. Macroscopic hydrogels can block larger vessels with a 
relatively small volume, affecting all downstream branches and resulting in massive ischemia. 
Commercially available HA dermal fillers for example, may cause irreversible blindness, due 
to blockage of the central retinal artery if injected into the supratrochlear artery.[33] Given the 
same injecting volume, the blockage caused by particle clumps, if any, would be limited due 
to their  potential dispersity and disaggregation at high shear rate. The collateral circulation 
and the compensatory mechanism would further reduce the infarction area. However, 
scattered infarctions of retinal capillaries, as seen in diabetic retinopathy, do not necessarily 
cause blindness.[34]  



















Figure 3. (a) Shear stress versus shear rate curves of particle suspensions and the commercial 
filler, and fitting with the Herschel-Bulkley model. (b) Effective viscosity versus shear rates 
curves of particle suspensions and the commercial filler. (c) Frequency dependence of storage 
modulus G’ and lost modules G” of the three suspensions. (d) Frequency dependence of 
storage modulus G’ and lost modules G” of the commercial filler.   
 
For comparison purposes, all samples rheologically characterised shared the same 
concentration with that of the commercial fillers (50 mg/ml). The effective viscosity was 
measured at 25°C using steady shear measurements. The variation of the shear stress and 
viscosity with shear rates are shown in Fig. 3a and 3b, respectively. The shear stress-shear 
rate data were fitted with the three parameters of Herschel-Bulkley model[17]  to provide 
additional insight into the rheology of the particle suspensions. The corresponding model 
parameters are given in Table 2. All samples demonstrated negligible yield stress and shear-
thinning (pseudoplastic) behaviour as indicated by their flow index n<1; mHA/PVP showed a 
more Newtonian like behaviour with its flow index approaching n=0.8. Notably, the viscosity 
of the commercial filler at zero shear is an order of magnitude higher than that of the 
fabricated hydrogel particles, which can be attributed to its continuous 3D molecular network 
structure (Fig. 3b), and drops sharply in the low-shear-rate region, in contrast to the gradual 
thinning behaviour observed in the present particle suspensions. Although the Herschel 
Bulkley model could not be fitted to the commercial filler data, extrapolation of the shear 
stress-shear rate data to zero shear indicates that the filler exhibits a relatively high yield stress 
(Fig. 3) and ‘thins’ rapidly when the shear rate increases. This explains the difficulties 
associated with injecting soft tissue fillers initially, and the sudden bursting out of the needle 
when the pressure applied exceeds a certain level - that of the filler yield stress. Should this 






Table 2. Rheological parameters of three hydrogel particle suspensions from Herschel-Bulkley model. 
 HA/PVP HA HA/PEG 
Yield stress, τy 0 0 0 
σ (τy) 0.58 5.82 9.32 
Consistency, K 2.31 26.66 41.93 
σ (K) 0.16 3.71 6.28 
Flow index, n 0.80 0.46 0.44 
σ (n) 0.01 0.03 0.03 
 
Compared to the commercial filler, the particle suspensions showed negligible yield stress and 
a gentler drop in viscosity in the low-shear-rate region, endowing the suspensions with better 
control during the injection process. It can be seen form Figure 3 and Table 1 that the three 
suspensions exhibit different shear thinning behaviour with the suspension of mHA/PVP 
particles exhibiting the lowest viscosity (2.39 mPas) at the low shear region.  This indicates 
that mHA/PVP can be easily injected with finer needles, causing less pain, [35] and reducing 
local inflammatory responses. It is also suitable for precise treatment of tiny depressions.  It is 
worth noting that PVP is used as lubricant in some eye drops. Particle morphology can partly 
explain the differences in the shear thinning behaviour of the three suspensions. For example, 
mHA/PVP particles are smooth and spherical (Fig. 2a) possibly due to a large number of 
hydrophilic pyrrolidone side groups on PVP chains that enhance the affinity between HA and 
PVP within the particles. Thus a rheological behaviour typical of hard spheres well studied in 
the literature should be expected; mHA/PEG and mHA particles on the other exhibit non-
spherical morphologies that are known to increase viscosity. mHA/PEG particles are shown to 
have a discoid shape and mHA an irregular oval shape which result in additional energy 
dissipation due to particle-particle interaction and particle orientation in flow. The porosity 
and surface roughness of the three particles as well as their Young modulus may also play a 






the same as the commercial HA filler, the volume fraction of the three suspensions might be 
slightly different and hence caution should be exercised when directly comparing the flow 
curves of the three suspensions.   
Dynamic rheological characterisation using frequency sweeps at a low strain amplitude 
(0.5%), showed that all three hydrogels exhibited time dependent viscoelasticity with an 
increase of the storage (G’) and loss moduli (G”) with increasing oscillatory frequency (Fig. 
3c and 3d). For all three suspensions, the values of G” were always larger than G’, indicating 
that viscous behaviour is predominant in the three suspensions due to the weak physical 
network among the hydrogel micro-particles. Nevertheless, mHA/PVP possesses the highest 
storage modulus and mHA/PEG the lowest among the three suspensions. This indicates a 
stiffening effect by PVP and softening by PEG In contrast, the G’ of the bulk gel (the 
commercial filler) was markedly higher than G’’, indicating dominance of elastic behaviour at 
small strains and stiffening at high frequency owing to its continuous network through both 
covalent and non-covalent bonding of HA chains.  
3.4 Microscale suspension flow dynamics 
A T-junction microfluidic system (Fig. 4a) was employed to evaluate the dispersity and flow 
dynamics of the hydrogel particle suspensions at the microscale, mimicking the injection 
condition process in surgical practice. A 500µm main channel with a 100 µm side branch was 
designed and fabricated in order to mimic the injection process through a 32-gauge needle, 
with an internal diameter of 97 µm, into a small vessel. A blood analog solution of 35% 
glycerol/65% water was perfused through the main channel at a constant flow rate of 100 
µl/min resulting in shear rates considered to be physiological at the level of the 
microcirculation.[36] The viscosity of the 35% glycerol solution was measured at 5.80 mPas, 






suspensions were observed to flow into the main channel, without forming aggregates sticking 













Figure 4. a) Schematic of A T-junction microfluidic system. (b-j) The flow fields of three 
particle suspensions at the T-injection port (b, e, h) and the site 1 cm away (c, f, i). As the 
arrow indicates, a 35% glycerol solution was fed into the main channel using a syringe pump. 
(d), (g) and (j) show the velocity distribution of three particle suspensions (external injection 
pressure = 28 kPa). The velocity vectors are normalised with the average velocity across the 
microfluidic channel obtained from the combined flowrate of the two streams in order to 
facilitate comparisons. The red indicates high velocity, while blue low velocity.  (b, c, d) 






The particle suspension flows (dispersed phase) enter the main channel with velocities 
ranging from around 20 to 60 mm/s depending on the type of hydrogel suspension delivered 
under controlled constant pressure. Upon encountering the continuous phase flow, a parallel 
(co-flow) flow pattern emerges characterised by the presence of a liquid-liquid interface 
separating a thin layer of the dispersed particle suspension and the continuous flow phase 
which move parallel to each other (Fig. 4b, 4e and 4h). As the main channel is 5 times wider 
than the side one the flow is fairly unconfined which, combined with the flow conditions of 
the experiment, result in the dispersed flow jet unable to penetrate deep into the main flow but 
rather to remain narrow and parallel to the channel wall.  The continuous flow velocity is 
comparable or lower to that of the dispersed phase (33 mm/s) and hence the shear forces are 
not sufficiently high to destabilise the interface of the incoming dispersed jet flow; hence the 
flow pattern appears fairly stable for a few channel widths downstream of the junction (Fig. 
4b, e, h). The two phases are both aqueous and hence partially miscible and particles manage 
to cross the interface and disperse into the water-glycerol solution because of their hydrophilic 
nature. Furthermore, the low interfacial tension between the two phases is expected to 
promote the formation of long threads or jets of the dispersed phase as suggested by 
literature[38] and these might be difficult to destabilise. Nevertheless, images obtained 20 
channel widths downstream of the T-junction (Fig. 4c, 4f and 4i) show that this is not the case. 
The three types of hydrogel micro-particles exhibit distinctly different flow behaviour.  Only 
the mHA/PVP particle suspension seems to remain flowing continuously near the channel 
wall with a gradually expanded particle suspension zone and a fairly stable liquid-liquid 
interface present. In contrast, both mHA/PEG and mHA dispersed phases appear to have lost 
their dynamic stability, as evidenced by the discontinuous or wavy interface seen in Fig 4f 
and 4i.  This can be attributed to the different flow and viscosity ratios between the 
continuous and dispersed phases among the three hydrogel suspension systems as well as their 






applying the same pressure differences in viscosity result in the dispersed phase to continuous 
phase velocity ratio to differ in the three systems.  The average inlet velocity of the mHA/PVP 
suspension was estimated to be almost twice that of the continuous phase (and its viscosity the 
lowest) which implies a high jet velocity suppressing or converting away any flow 
perturbations and hence promoting the formation of a continuous dispersed flow stream near 
the wall.   This can be seen in Fig. 4d in which the vector field of the mHA/PVP dispersed 
flow, obtained through quantitative imaging techniques, is superimposed on the acquired 
images. The high velocities of the incoming dispersed flow jet are evident.  On the contrary, 
mHA/PEG and mHA are more viscous than the HA/PVP and hence enter the T-junction with 
slightly lower velocities. As a result the velocity ratio between the dispersed and continuous 
phase is lower (20 and 50 mm/s) and the viscosity ratio higher compared to that in the 
mHA/PVP case, which destabilises the dispersed phase stream. The vector plots in Fig. 4g 
and 4j illustrate the different flow behaviour of the mHA/PEG and mHA suspensions 
characterised by lower flow velocities in comparison to the mHA/PVP case and high 
velocities been confined in a small region near the interface.  
It should be noted that unlike reported liquid-liquid flows in T-microchannels, the dispersed 
flows in the present study comprise particle suspensions. Particle suspensions are known to 
exhibit shear induced migration at low shear flows; this migration depends on particle 
properties as well as the viscoelasticity of the matrix and may further contribute to the flow 
dynamics of the suspensions under study. The surface chemistry, and morphologies of the 
three types of particles differ markedly despite sharing the same concentration (wt %) in their 
suspension. It can be argued that the microflow behaviour of the mHA/PVP particle 
suspension can also be attributed to reduced migration, compared to anisotropic discoid 
shaped mHA/PEG and irregular porous mHA particles that are expected to exhibit potential 






Furthermore, blood itself is a soft particle suspension and its behaviour cannot be accurately 
replicated by blood analogs such as the one employed in the present study. Red blood cells 
may interact with the hydrogel particles resulting in non-uniform particle distributions across 
the channel and hence a local viscosity variation. For example, red blood cells are known to 
cause margination of drug delivery particles.[39] Such effects depend on particle 
characteristics and merit further investigation, which is beyond the scope of this study.  
Finally, according to aggregation theory, low shear conditions can cause clustering of 
neighbouring particles, and thus formation of aggregates.[40]. Shear induced aggregation is a 
well documented phenomenon of particle suspensions and is reversible, i.e. aggregates break 
down as shear is increased. In the context of the present study, such aggregate formations can 
potentially block the channel and form gel emboli. The flow rates employed in the present 
study (100 µL/min) result in nominal shear rates of around 300 s
-1
; these are physiological for 
microvascular flows and relatively high for aggregate formation; however, a shear rate 
distribution is expected in the microchannel which might favour local aggregate formation.[41] 
No such aggregate formation was observed for the three hydrogel particle systems under the 
low flow conditions studied and hence it is unlikely that the channel would be occluded with 
higher flow velocities.   
3.5 Swelling ability 
The mass swelling ratio (MSR) has been used to quantify the water absorption of HA.[42, 43] 
Since the MSR is inversely related to the crosslinking degree, hydrogels with a high MSR 
may also have a limited longevity in the human body, due to the low crosslinking degree and 
thus the reduced resistance to hyaluronidases.  
Although no significant difference was found among the three hydrogel particles, all the 






commercial filler sample (23.63, p < 0.005) (Table 1). This indicated that the particles had a 
higher crosslinking degree. Potential experimental errors of under-measurement of the MSR 
of the particles should be taken into account because of possible over-drying process of the re-
hydrated particles with large surface areas compared to the commercial filler samples.  
Nevertheless, despite of the dried large surface, the water bound stably within the hydrogel 
particles should still represent main contribution to the increase of the particles’ weight.  The 
MSR of mHA/PVP and mHA/PEG is slightly lower than mHA, indicating a reduced water 
absorption in the presence of semi-interpenetrated network with synthetic PVP and PEG. 
Thus, we speculate that mHA/PVP and mHA/PEG particles may have a longer in vivo 
retention, in favour of drug delivery or filling performance which would require further tests 
in animal model.  
3.6 In vitro enzymatic degradation kinetics 
The Morgan-Elson reaction is a widely used method to evaluate the degradation products of 
HA.[44] As fragments of membrane-bound PH-20 enzymes,[45] hyaluronidases from tests 
have been shown to degrade HA macromolecules mainly into tetrasaccharides,[46, 47] when 
complete degradation takes place.  
The measured concentrations of N-acetyl-D-glucosamine were 0.003 ± 0.001, 0.003 ± 0.001, 
0.004 ± 0.001 mol/L at the 1.5-hour point, for mHA/PVP, mHA/PEG and mHA, respectively. 
At the 3-h point, the concentrations went up to 0.004 ± 0.001, 0.005 ± 0.0005, and 0.006 ± 
0.003 mol/L, respectively. The functionalized particles showed a trend that they degraded 
slightly more slowly than mHA. Considering the molecular network within the particles, the 
modification of PVP/PEG had two contradictive effects on enzymatic degradation. On one 
hand, the incorporation of these polymers into the hydrogel network may interfere with the 
formation of more stable crosslinking networks among HA macromolecules, in favour of fast 






modification would reduce such an exposure at the interfaces. Based on the colorimetry assay, 
it appeared that the two contradictive effects offset each other, and resulted in degradation 
kinetics similar to that of mHA. This result indicated the possibility to functionalize HA as 
needed without significantly changing the degradation profile. 
3.7 Effects on thrombosis 
Whether or not the microgels would activate the coagulation cascade reaction is clinically 
significant. In the clinical scenario where blood vessels are blocked by the microgel particles, 
those gel emboli tending to cause secondary thrombosis would complicate the embolism and 
worsen the local ischemia. Thromboelastography (TEG) was selected to evaluate the effects 
on thrombosis, as it provided essential results reflecting the comprehensive interactions in the 
whole blood, including: 
 R value: the time until the very first evidence that a clot is detected; 
 K value: the duration between R and the time when the clot grows to 20mm;  
 Angle α: the tangent of the curve plotted when the K value is obtained;  
 Maximum amplitude (MA): the maximum amplitude of the curve plotted, reflecting the 
strength of the clot. 
Based on the above-mentioned four essential values, the coagulation index (CI) can be 
calculated with a formula provided by the manufacturer. The CI value is a simple and useful 
clinical index that reflect the overall status of coagulability. 
CI = 0.3258R – 0.1886K + 0.1224MA +0.0759α – 7.7922 
The reference range of CI is from -3.0 to +3.0. A CI value greater than +3.0 indicates a status 






Table 3. Essential values obtained with thromboelastography 
Group Angle α(°) Maximum 
amplitude 
(mm) 
R (min) K (min) Coagulation 
index 
mHA/PVP 32.9 ± 4.48 44.6 ± 3.04 11.83 ± 4.01 6.13 ± 1.15 2.86 ±0.74 
mHA/PEG 20.73 ±2.51 28.67 ±1.46 17.40 ±1.57 10.17 ±1.53 1.04 ±0.12 
mHA 25.93 ±5.48 31.13 ±0.85 16.40 ±2.25 7.97 ±2.45 1.83 ±0.96 
Commercial 
filler 
30.47 ±9.45 42.70 ±3.70 14.37 ±3.61 6.73 ±2.30 3.15 ±0.27 
 
The essential values obtained by TEG applied to the present study in fresh citrated whole 
blood, listed in Table 3. The mHA/PVP seemed to have no effect on either the rate of 
thrombosis (p>0.999) or the strength of the clot (p=0.892). Both mHA (p< 0.001) and 
mHA/PEG (p<0.001) appeared able to decrease the strength of the clot, but only mHA/PEG 
was found to slow down the thrombosis process (p=0.048). This suggests that blood clots 
involving mHA/PEG may have a higher influence on thrombolysis therapy. Whether the 
dumbbell shape of the particles or the surface chemistry of PEG or both contributed to the low 
thrombosis effect of mHA/PEG merits further investigation.  Based on the CI values in Table 
3, the microgels prepared with our protocol were not found to influence the overall 
coagulability. This suggests that secondary thrombosis may serve as a minor cause after the 
microgels were injected into a blood vessel. Thus, in case the blood vessel is blocked in such 
a scenario, the gel emboli resulting from microgel aggregates can be considered as the main 
cause. However, as mentioned in section 3.4, no such aggregates were observed during the 
microfluidic experiments mimicking a surgical procedure under physiological condition. As a 




















Figure 5 (a) AlamarBlue assay results on day 6 (n = 3); (b) Total DNA quantification on day 6 
(n=3); (c-e) Examination of Rhodamine 6G loading status using 532 nm light. Separate dots 
emitting strong yellow light were observed, indicating the dye was encapsulated within 
hydrogel particles.  (f) In vitro releasing kinetics of Rhodamine 6G from hydrogel particles, 
with enzymatic degradation, measured at 539nm.  
The metabolic level and the viability of human dermal fibroblasts were evaluated with the 
alamarBlue assay and total DNA quantification, respectively (Fig. 5a and 5b). AlamarBlue 
assay has been widely used to assess cell viability and cytotoxicity via cell metabolic activity. 
In the alamarBlue assay, no toxic effects were observed (Fig. 5a). With both particle 






(ANOVA; 1 mg/ml, p = 0.71; 2 mg/ml, p = 0.316). The viability was evaluated with the total 
DNA quantification (ANOVA; 1 mg/ml, p = 0.557; 2 mg/ml, p = 0.084) (Fig. 5b), supporting 
the result of the alamarBlue assay. All the experiment groups demonstrated a trend that the 
crosslinked particles were in favour of cell survival. 
In the present study, single doses of suspensions at two different final concentrations (i.e. 1 
mg/ml and 2 mg/ml) were given to cell cultures (6200 cells/well). On day 6, both the results 
of the alamarBlue assay and the total DNA quantification showed that the hydrogel particles 
had no significant negative effects on cellular metabolism or viability, compared to the PBS 
control. This indicates that HA-based hydrogel particles have a minimal subacute toxicity, if 
any. Similar results were observed in other HA hydrogel and HA-containing 
microparticles.[49] The results further prove that HA, as an important member of the cellular 
matrix, is able to enhance cell spreading, migration, and proliferation.[50] In addition, the 
relatively stiffer surfaces of crosslinked hydrogel particles, the uneven particle sizes, and the 
shapes of individual particles may increase the complexity of the local topography 
surrounding the cells, and thus may result in complex interactions with the cytoskeleton 
system.[51] 
 
3.9 Preliminary loading and release test 
To assess whether the functionalized particles were able to load hydrophilic compounds, a 
hydrophilic dye, Rhodamine 6G, was selected as the representative compound. The loading 
status of Rhodamine 6G in hydrogel particles was qualitatively examined under a fluorescent 
microscope, stimulated with 532 nm light. Under the microscope (×40), separate bright 
yellow dots were observed, which indicated that the hydrophilic dye was successfully 






The in vitro release kinetics was assessed in a hyaluronidase environment by recording the 
absorbance of the supernatant at 539 nm. A steady release was observed with mHA/PVP and 
mHA/PEG, while mHA demonstrated a burst release of the dye (Fig. 5f). As mentioned 
previously, the degradation kinetics was similar for all three particles. As a result, the 
releasing kinetics shown in Fig. 5e mainly reflected the spontaneous release. The figure 
showed a higher level of releasing with mHA, while the functionalized HA particles 
(mHA/PVP and mHA/PEG) showed a steady release rate during the 3 hours exposed to the 
hyaluronidase solution. This result indicated that the densely packed mHA/PVP and 
mHA/PEG particles and intact backbone chains of PVP and PEG may impede the loss of 
entrapped Rhodamine 6G. It would be important for drug delivery systems, as the result 




Three kinds of HA-based hydrogel particles, mHA/PVP, mHA/PEG, and mHA, have been 
developed and served as the representatives of non-covalent, covalent semi-interpenetrating 
and conventional 3D molecular networks, respectively. Hydrogel micro-particles exhibited 
diameters between 2.5 and 3.5 µm and their structure and properties depended on the nature 
of the polymer introduced to the network. The smooth spherical mHA/PVP particles and 
biconcave mHA/PEG particles indicate the denser chain packing throughout the network, 
compared with porous irregular mHA particles. The rheological tests confirmed the tuneable, 
shear-thinning property of the suspensions, in addition to an improved injection controllability, 
compared to the commercial bulk filler. The safety profiles of the hydrogel particles were 
tested in terms of the dynamic dispersity and stability in microchannels, subacute cytotoxicity, 






compared to the commercial filler.  The particles also demonstrated the capacity to load and 
release hydrophilic compounds. Among the particles, the modified ones seemed to be superior 
to the unmodified HA particles, in terms of injectability, dispersity, and drug releasing 
kinetics. Spherical mHA/PVP particle suspensions exhibited the most desirable linear (nearly 
Newtonian) flow behaviour, dynamic dispersity, and stability. Based on the results above, 
modified HA-based particles are promising materials for new soft tissue fillers and drug 
delivery. Hence, the development of a micro-hydrogel system by formation of semi-
interpenetrating 3D network has been demonstrated as a cost-effective way to develop novel 
hydrogel and hydrogel particles for meeting various medical needs. 
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Figure 1. (a)-(c) Schematic showing semi-interpenetrating network of HA/PVP (a). 
interpenetrating network of HA/PEG (b) and network of HA(c). (d) FTIR spectra of the three 
hydrogel microparticles. (e) Vector normalized second order derivative FTIR spectra between 
1575 and 1595 cm
-1
, generated with the Savitsky-Golay algorithm, which narrowed the 
bandwidths and increased the resolution of differential spectra. In uncrosslinked hyaluronic 
acid, the peak around 1585 cm-1 represented N-H bending, which was used as a marker of 
HA molecules.  
 
Figure 2. SEM images showing the morphology of microparticles made from mHA/PVP (a) 
and (d), mHA/PEG (b) and (e) and mHA (c) and (f).  
 
Figure 3. (a) Shear stress versus shear rate curves of particle suspensions and the commercial 
filler, and fitting with the Herschel-Bulkley model. (b) Effective viscosity versus shear rates 
curves of particle suspensions and the commercial filler. (c) Frequency dependence of storage 
modulus G’ and lost modules G” of the three suspensions. (d) Frequency dependence of 
storage modulus G’ and lost modules G” of the commercial filler.   
 
Figure 4. a) Schematic of A T-junction microfluidic system. (b-j) The flow fields of three 
particle suspensions at the T-injection port (b, e, h) and the site 1 cm away (c, f, i). As the 
arrow indicates, a 35% glycerol solution was fed into the main channel using a syringe pump. 
(d), (g) and (j) show the velocity distribution of three particle suspensions (external injection 
pressure = 28 kPa). The velocity vectors are normalised with the average velocity across the 






facilitate comparisons. The red indicates high velocity, while blue low velocity.  (b, c, d) 
mHA/PVP; (e, f, g) mHA/PEG; (h, i, j) mHA.  
 
 
Figure 5 (a) AlamarBlue assay results on day 6 (n = 3); (b) Total DNA quantification on day 6 
(n=3); (c-e) Examination of Rhodamine 6G loading status using 532 nm light. Separate dots 
emitting strong yellow light were observed, indicating the dye was encapsulated within 
hydrogel particles.  (f) In vitro releasing kinetics of Rhodamine 6G from hydrogel particles, 












Table 1. Summary of structure and properties of the peaks detected in hydrogel particle suspensions 
 mHA/PVP mHA/PEG            mHA 
DLS No. of peak 1 1 1 
Particle diameter/ µm 2.80 ± 0.35 3.70 ± 0.38 2.74 ± 0.310 
Polydispersity index, PDI 0.07 ± 0.03 0.08 ± 0.03 0.08 ± 0.02 
Relative HA content% 56 80 83.6 
Mass swelling ratio, MSR 7.01 7.93 10.40 
 
 
Table 2. Rheological parameters of three hydrogel particle suspensions from Herschel-Bulkley model. 
 HA/PVP HA HA/PEG 
Yield stress, τy 0 0 0 
σ (τy) 0.58 5.82 9.32 
Consistency, K 2.31 26.66 41.93 
σ (K) 0.16 3.71 6.28 
Flow index, n 0.8 0.46 0.44 
σ (n) 0.01 0.03 0.03 
 
Table 3. Essential values obtained with thromboelastography 
Group Angle α(°) Maximum 
amplitude 
(mm) 
R (min) K (min) Coagulation 
index 
mHA/PVP 32.9 ± 4.48 44.6 ± 3.04 11.83 ± 4.01 6.13 ± 1.15 2.86 ±0.74 
mHA/PEG 20.73 ±2.51 28.67 ±1.46 17.40 ±1.57 10.17 ±1.53 1.04 ±0.12 
mHA 25.93 ±5.48 31.13 ±0.85 16.40 ±2.25 7.97 ±2.45 1.83 ±0.96 
Commercial 
filler 
30.47 ±9.45 42.70 ±3.70 14.37 ±3.61 6.73 ±2.30 3.15 ±0.27 
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